News

Home > News > News

2019/04/25

CCSB obtained a US patent of Ribociclib succinate.

The United States Patent and Trademark Office has granted Chunghwa Chemical Synthesis & Biotech Co. Ltd. (CCSB) a patent of Crystal forms B, C, and D of Ribociclib succinate salts and derivative thereof, and their preparation method and composition thereof

 Patent no.: US 10336763 B1.